Major Investor Group Reduces Stake in KORU Medical Systems by 1.69%
summarizeSummary
Horton Capital Partners and Joseph M. Manko, Jr. have reduced their aggregate beneficial ownership in KORU Medical Systems, Inc. by 782,547 shares, representing a 1.69% decrease in their stake, primarily through in-kind distributions to limited partners.
check_boxKey Events
-
Significant Stake Reduction
Horton Capital Partners and Joseph M. Manko, Jr. reduced their aggregate beneficial ownership by 782,547 shares, decreasing their stake from 14.31% to 12.62%.
-
In-Kind Distributions
The reduction was primarily due to in-kind distributions of shares from Horton Capital Partners Fund, LP to its limited partners, and subsequently to its members, including Joseph M. Manko, Jr.
-
Director's Involvement
Joseph M. Manko, Jr., a director of KORU Medical Systems, is part of the reporting group that reduced its overall beneficial ownership.
auto_awesomeAnalysis
This Schedule 13D/A reports a significant reduction in the beneficial ownership of KORU Medical Systems by Horton Capital Partners and its managing member, Joseph M. Manko, Jr., who also serves as a director. The group's aggregate stake decreased by 782,547 shares, or 1.69% of the company's outstanding common stock, since their last filing. This reduction, valued at approximately $3.65 million based on today's stock price, primarily stems from in-kind distributions of shares from the fund to its limited partners. While these are not open market sales, the decrease in a major investor group's overall position, which includes a director, could be interpreted as a slight negative signal regarding their long-term conviction or a strategic rebalancing of their portfolio. Investors should monitor future filings for any further changes in this group's ownership.
At the time of this filing, KRMD was trading at $4.67 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $216.3M. The 52-week trading range was $1.86 to $6.61. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.